| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 570 | 498 |
| Net increase in cash and cash equivalents | 22,544 | 15,632 |
| Cash and cash equivalents at beginning of period | 72,670 | - |
| Cash and cash equivalents at end of period | 95,214 | - |
PLIANT THERAPEUTICS, INC. (PLRX)
PLIANT THERAPEUTICS, INC. (PLRX)